Aligos therapeutics to present preliminary antiviral activity of alg-000184 in chronic hepatitis b (chb) subjects at hbv-tag conference

Subjects experienced a 2.9 log 10 iu/ml mean reduction in hbv dna levels after 14 days' dosing with 100 mg alg-000184
ALGS Ratings Summary
ALGS Quant Ranking